Drug intelligence / Profile preview

AUX-003

Development stage: Unknown
Lead developer: Auxilius Pharma
Administration: Oral

Overview

**AUX-003** is an early-development, formulation-stage cardiovascular drug candidate from Auxilius Pharma. Public sponsor material describes AUX-003, alongside AUX-002, as being intended for development as a fixed-dose combination designed to improve treatment adherence and efficacy in the anti-anginal cardiovascular-care setting; its active ingredients, molecular modality, pharmacologic targets, mechanism of action, route, dosage form, and specific indication have not been publicly disclosed. ([auxiliuspharma.com](https://auxiliuspharma.com/posts/20241111pharmashotscxotalks/))

Beyond the preview

Go deeper on AUX-003.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AUX-003.

Explore the full profile